Benzinga | Nov 2, 2020 04:25PM EST

Neuronetics Q3 EPS $(0.18) Beats $(0.27) Estimate, Sales $12.40M Beat $11.56M Estimate

Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.27) by 33.33 percent. This is a 51.35 percent increase over losses of $(0.37) per share from the same period last year. The company reported quarterly sales of $12.40 million which beat the analyst consensus estimate of $11.56 million by 7.27 percent. This is a 22.50 percent decrease over sales of $16.00 million the same period last year.